CatalYm Publishes Data in Nature Communications Describing GDF-15 as a Central Factor of anti-PD-1 Resistance
MUNICH--(BUSINESS WIRE)--Jul 20, 2023--<a ...
MUNICH--(BUSINESS WIRE)--Jul 20, 2023--<a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 19, 2023--<a ...
SAN DIEGO--(BUSINESS WIRE)--Jul 19, 2023--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced a favorable coverage policy with a Blues plan in Michigan. The favorable coverage policy, ...
SAN FRANCISCO--(BUSINESS WIRE)--Jul 19, 2023--Circle Pharma, a biopharmaceutical company advancing the discovery and development of intrinsically cell-permeable macrocycles, announced today the selection of CID-078 for its first clinical development program. CID-078 is the ...
<p style="TEXT-ALIGN:CENTER">Verismo Therapeutics has raised a total of $50M since launchingPHILADELPHIA, July 18, 2023 /PRNewswire/ -- <a ...
DUBLIN--(BUSINESS WIRE)--Jul 18, 2023--The <a ...